Background: Endoscopic ultrasonography (EUS)-guided choledochoduodenostomy (CDS) is as an alternative to percutaneous transhepatic biliary drainage (PTBD) in patients with biliary obstruction when endoscopic retrograde biliary drainage (ERBD) is unsuccessful. Purpose: We reviewed our experience and technique in patients undergoing EUS-CDS. Patients: Over a 2-year period to December 2008, 15 patients with unsuccessful ERBD underwent EUS-CDS. Methods: EUS-guided needle puncture was performed to access the bile duct from the duodenal bulb. After cholangiography, a guidewire was inserted through the needle and directed to the hepatic hilum. The punctured fistula was then dilated with a biliary dilator and a plastic stent was inserted. Results: The technical success rate of EUS-CDS was 93% (14/15 patients); 1 patient underwent an EUS-guided rendezvous approach because the choledochoduodenal fistula could not be dilated. Decompression of the bile duct was achieved in all patients. Complications included cholangitis in 4 patients, self-limiting local peritonitis in 2 and distal stent migration in 1 patient. The median follow-up time was 125 days and the median duration of stent patency was 99 days. Conclusion: EUS-CDS may be effective for patients following unsuccessful ERBD and offers an attractive alternative to PTBD.

Keywords:
Choledochoduodenostomy, Endoscopic ultrasonography, Endoscopic retrograde biliary drainage, Percutaneous transhepatic biliary drainage
1.
Huibergstse K, Kimmery MB: Endoscopic retrograde cholangiopancreatography, endoscopic sphincterotomy and endoscopic biliary and pancreatic drainage; in Yamada T (ed): Textbook of Gastroenterology. Philadelphia, Lippincott, 1995, pp 2590–2627.
2.
Choudari CP, Sherman S, Fogel EL, et al: Success of ERCP at a referral center after a previously unsuccessful attempt. Gastrointest Endosc 2000;52:478–483.
3.
Ferruccci JT Jr, Mueller PR, Harbin WP: Percutaneous transhepatic biliary drainage: technique, result, and applications. Radiology 1980;135:1–13.
4.
Harbin WP, Mueller PR, Ferrucci JT Jr: Transhepatic cholanginography: complications and use patterns of the fine-needle technique: a multi-institutional survey. Radiology 1980;135:15–22.
5.
Smith AC, Dowsett JF, Russsell RC, et al: Randomized trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 1994;344:1655–1660.
6.
Sakamoto H, Kitano M, Nishio T, et al: Value of computed tomography for evaluating the injection site in endosonography-guided celiac plexus neurolysis. Dig Endosc 2006;18:206–211.
7.
Kanazawa M, Yoshihara K, Abel H, et al: Two case reports on intra-tumor injection therapy of dendritic cells (in Japanese). Gan To Kagaku Ryoho 2005;32:1571–1573.
8.
Kitano M, Sakamoto H, Komaki T, et al: Present status and future perspective of EUS-guided drainage. Dig Endosc 2009;21:66–70.
9.
Will U, Fueldner F, Thieme AK, et al: Transgastric pancreatography and EUS-guided drainage of the pancreatic duct. J Hepatobiliary Pancreat Surg 2007;14:377–382.
10.
Giovannini M, Moutardier V, Pesenti C, et al: Endoscopic ultrasound-guided bilioduodenal anastomosis: a new technique for biliary drainage. Endoscopy 2001;33:898–900.
11.
Carr-Locke DL: Overview of the role of ERCP in the management of diseases of the biliary tract and the pancreas. Gastrointest Endosc 2002;56(suppl 6):S157–S160.
12.
Raymondos K, Panning B, Bachem I, et al: Evaluation of endoscopic retrograde cholangiopancreatography under conscious sedation and general anesthesia. Endoscopy 2002;34:721–726.
13.
Wright BE, Case OW, Freeman ML: ERCP in patients with long-limb Roux-en Y gastrojejunostomy and intact papilla. Gastrointest Endosc 2000;52:478–483.
14.
Lameris JS, Stoker J, Nijs HG, et al: Malignant biliary obstruction: percutaneous use of self-expandable stents. Radiology 1991;179:703–707.
15.
Beissert M, Wittenberg G, Sandstede J, et al: Metallic stents and plastic endoprostheses in percutaneous treatment of biliary obstruction. Z Gastroenterol 2002;40:503–510.
16.
Kama NA, Coskun T, Yuksek YN, et al: Factors affecting post-operative mortality in malignant biliary tract obstruction. Hepatogastroenterology 1999;46:103–107.
17.
Burmester E, Niehaus J, Leineweber T, et al: EUS-cholangio-drainage of the bile duct: report of 4 cases. Gastrointest Endosc 2003;57:246–251.
18.
Puspok A, Lomoschitz F, Dejaco C, et al: Endoscopic ultrasound guided therapy of benign and malignant biliary obstruction: a case series. Am J Gastroenterol 2005;100:1743–1747.
19.
Kahaleh M, Wang P, Shami VM, et al: Drainage of gallbladder fossa fluid collections with endoprosthesis placement under endoscopic ultrasound guidance: a preliminary report of two cases. Endoscopy 2005;37:393–396.
20.
Ang TL, Teo EK, Fock KM: EUS-guided transduodenal biliary drainage in unresectable pancreatic cancer with obstructive jaundice. JOP 2007;8:438–443.
21.
Yamao K, Sawaki A, Takahashi K, et al: EUS-guided choledochoduodenostomy for palliative biliary drainage in case of papillary obstruction: report of 2 cases. Gastrointest Endosc 2006;64:663–667.
22.
Yamao K, Bhatia V, Mizuno N, et al: EUS-guided choledochoduodenostomy for palliative biliary drainage in patients with malignant biliary obstruction: results of long-term follow-up. Endoscopy 2008;40:340–342.
23.
Tarantino I, Barresi L, Repici A, et al: EUS-guided biliary drainage: a case series. Endoscopy 2008;40:336–339.
24.
Fujita N, Noda Y, Kobayashi G, et al: Histological changes at an endosonography-guided biliary drainage site: a case report. World J Gastroenterol 2007;13:5512–5515.
25.
Itoi T, Itokawa F, Sofuni A, et al: Endoscopic ultrasound-guided choledochoduodenostomy in patients with failed endoscopic retrograde cholangiopancreatography. World J Gastroenterol 2008;14:6078–6082.
26.
Hanada K, Iiboshi T, Ishii Y: Endoscopic ultrasound-guided choledochoduodenostomy for palliative biliary drainage in cases with inoperable pancreas head carcinoma. Dig Endosc 2009;21(suppl 1):S75–S78.
27.
Park do H, Koo JE, Oh J, et al: EUS-guided biliary drainage with one-step placement of a fully covered metal stent for malignant biliary obstruction: a prospective feasibility study. Am J Gastroenterol 2009;104:2168–2174.
© 2011 S. Karger AG, Basel and IAP
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.